Correlation Between Coherus BioSciences and Bolt Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coherus BioSciences and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coherus BioSciences and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coherus BioSciences and Bolt Biotherapeutics, you can compare the effects of market volatilities on Coherus BioSciences and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coherus BioSciences with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coherus BioSciences and Bolt Biotherapeutics.

Diversification Opportunities for Coherus BioSciences and Bolt Biotherapeutics

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Coherus and Bolt is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Coherus BioSciences and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Coherus BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coherus BioSciences are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Coherus BioSciences i.e., Coherus BioSciences and Bolt Biotherapeutics go up and down completely randomly.

Pair Corralation between Coherus BioSciences and Bolt Biotherapeutics

Given the investment horizon of 90 days Coherus BioSciences is expected to generate 3.32 times more return on investment than Bolt Biotherapeutics. However, Coherus BioSciences is 3.32 times more volatile than Bolt Biotherapeutics. It trades about 0.32 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.21 per unit of risk. If you would invest  72.00  in Coherus BioSciences on August 28, 2024 and sell it today you would earn a total of  49.00  from holding Coherus BioSciences or generate 68.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Coherus BioSciences  vs.  Bolt Biotherapeutics

 Performance 
       Timeline  
Coherus BioSciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Coherus BioSciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Bolt Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bolt Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Coherus BioSciences and Bolt Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coherus BioSciences and Bolt Biotherapeutics

The main advantage of trading using opposite Coherus BioSciences and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coherus BioSciences position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.
The idea behind Coherus BioSciences and Bolt Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences